thm glp 1 GLP-1 Support, Essential Sources – Professional Supplement Center 🍊GLP-1 | Tri-Health Wellness Centre

While previous studies have reported a reduced risk of developing PD in diabetic patients using GLP-1 receptor agonists, likely due to improved glucose metabolism and reduced neuroinflammatory burden, it is important to note that the trials assessing their efficacy in managing PD and included in our analysis applied a diagnosis of diabetes as an exclusion criterion

Based on these findings, clinical trials, particularly those involving Exenatide and Lixisenatide, have explored their potential to modify the course of PD, however, recent findings have been less promising than anticipated

I reached out directly to my pharmacy, and it was fast

Brown JB, Nichols GA, Perry A

doi: 10.1016/j.physbeh.2011.12.001

Eli Lilly is moving fast, with a 2025 submission for obesity and an aggressive early 2026 launch timeline